NCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
Clinical Trials
9 trialsNCT00569543 2023-09-01
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
University of Nebraska
Completed
NCT00959244 2023-09-01
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105
University of Nebraska
Completed
NCT00900367 2019-08-13
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
Brigham and Women's Hospital
Unknown
NCT00897208 2018-10-05
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
Mayo Clinic
Completed
NCT00873366 2018-01-23
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Mayo Clinic
Terminated
NCT00516698 2016-07-13
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Alliance for Clinical Trials in Oncology
Completed
NCT00463034 2013-12-18
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00691509 2013-08-26
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
National Cancer Institute (NCI)
Unknown